Statement for the Record: “Open Executive Session to Consider an Original Bill Entitled the Prescription Drug Pricing Reduction Act of 2019”
Chairman Grassley, Ranking Member Wyden, and distinguished Members of the Senate Committee on Finance, on behalf of the Medicare Rights